Provided by Tiger Trade Technology Pte. Ltd.

Glaukos

163.17
-1.0200-0.62%
Post-market: 163.170.00000.00%19:30 EDT
Volume:808.41K
Turnover:132.59M
Market Cap:9.62B
PE:-50.27
High:168.73
Open:164.00
Low:162.08
Close:164.19
52wk High:191.62
52wk Low:73.16
Shares:58.98M
Float Shares:56.44M
Volume Ratio:0.87
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2456
EPS(LYR):-3.2819
ROE:-25.98%
ROA:-5.18%
PB:14.10
PE(LYR):-49.72

Loading ...

Glaukos price target raised to $162 from $140 at Citi

TIPRANKS
·
Jun 11

U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle

Reuters
·
Jun 11

Stifel Nicolaus Sticks to Their Buy Rating for Glaukos (GKOS)

TIPRANKS
·
Jun 10

Glaukos: Buy Rating Reiterated on Robust Pipeline and Multi-Product Growth Drivers; $162 Price Target Unchanged

TIPRANKS
·
Jun 10

Analyst Reiterates Buy on Glaukos, Maintains $136 Price Target Amid Stable LCD Outlook and Long-Term Growth Potential

TIPRANKS
·
Jun 10

Glaukos Price Target Maintained With a $162.00/Share by BTIG

Dow Jones
·
Jun 10

Glaukos (GKOS) Valuation Check As iDose TR Adoption Renews Growth Expectations

Simply Wall St.
·
Jun 10

Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and Glaukos (GKOS)

TIPRANKS
·
Jun 07

Glaukos Shareholders Reinforce Board, Pay and Auditor Support

TIPRANKS
·
Jun 04

Glaukos shareholders elect two directors at annual meeting

Reuters
·
Jun 04

Analyst Reiterates Buy on Glaukos, Citing Long-Term iDose Opportunity and Upcoming Epioxa-Driven Growth

TIPRANKS
·
Jun 03

Glaukos pullback due to concerns about iDose LCD, says William Blair

TIPRANKS
·
May 27

Goldman Sachs Reaffirms Their Buy Rating on Glaukos (GKOS)

TIPRANKS
·
May 26

Steven Lichtman Reiterates Buy on Glaukos, Citing Manageable Coverage Risk and Robust Multiyear iDose Growth Outlook

TIPRANKS
·
May 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM), PepGen Inc. (PEPG) and Glaukos (GKOS)

TIPRANKS
·
May 22

Glaukos: Buy Rating Reiterated as Favorable iDose LCD Eases Reimbursement Overhang and Sets Stage for Epioxa-Driven Growth

TIPRANKS
·
May 22

Glaukos Corp : Btig Raises Target Price to $162 From $141

THOMSON REUTERS
·
May 21

Glaukos Is Maintained at Buy by BTIG

Dow Jones
·
May 21

Glaukos director Gilbert H. Kliman disposes 5,000 common shares for $703,800

Reuters
·
May 19

Glaukos director Gilbert H. Kliman disposes of 5,000 common shares for $675,000

Reuters
·
May 14